ARCHIVES

Dendreon Claims “Clear Hit” On Provenge, But Skeptics Await Data Presentation

This article is from The Cancer Letter archive.

Vol. 35 No. 15 | April 17, 2009

Download PDF Visit The Full Archive

Related Articles

In Brief: Terry To Leave NCI for Job As VP Of Revlon Health Care Group; NCI Tracking Source Of Breakthroughs

June 18, 1982

Knowing Tumor Cell Structure Improves Treatment Decisions

March 27, 2009

Obey Says NCI “Must Do Better,” Response Dispute GAO Conclusion

August 8, 1980

Number of Clinical R01 Applications Doubles; Funding Rate Below 20%; NCI Execs Not Satisfied

July 17, 1992

Cancer Advocacy: March On Washington Scheduled For September 1998

October 31, 1997

AACR Changes Its Logo— For The Fifth Time Since 2000

June 11, 2014